Aarti Drugs gets order boost, slips on profit sales

DALAL STREET SPIKES

Aarti Drugs spurted in intra-day trades after the company announced about bagging a huge order. After hitting an intra-day high of Rs 179.90 (up 7.1 per cent), the stock slipped on profit booking across the board. The stock finally ended at Rs 166.25, down 0.66 per cent.

The company announced that it has finalised a major export order for anti-fouling agent to be supplied for a period of 7 years. The total value of the order is more than $4.5 million (Rs 200 crore).

On back of the announcement, the counter witnessed impressive volumes of over 4.9 lakh shares on BSE. The stock has witnessed a dream run of late. From a low of Rs 109.65 on May 5, the stock has appreciated to Thursday's close of Rs 166.25. Aarti Drugs customers include Pfizer, Searle, Knoll Pharmaceuticals, Glaxo, E Merck, etc.